Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...

Smoothie King's GLP-1 Support Menu caters to customers using drugs like Ozempic, but the lack of plant-based options is a big ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

The Life Sciences Industry Report: Trends & Predictions 2025 is built for those who are serious about growth, innovation, and ...

Certain GLP-1 medications, like Ozempic ... Adding this shot to the tool kit, next to ice baths and protein shakes, can help ...

Hims & Hers currently offers compounded GLP-1 weight-loss injections at $199 per month and weight management oral medication ...

Q3 2024 Earnings Call Transcript November 4, 2024 Medifast, Inc. beats earnings expectations. Reported EPS is $0.1029, ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

Key findings include: Customers using oral medication kits on average, lost 7.5 pounds - approximately 3.6% of their initial body weight - in their first month. Customers using compounded GLP-1s ...

Weight loss is not a one-size-fits-all solution. What works for one person may not work for another, and even the most effective treatments may need adjustments over time. That’s why ScriptsMD’s ...

Q3 2024 Earnings Call Transcript November 7, 2024 ClearPoint Neuro, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Q3 2024 Earnings Call Transcript November 6, 2024Amphastar Pharmaceuticals, Inc. misses on earnings expectations.